Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis
Status:
Recruiting
Trial end date:
2026-11-06
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine if Nexium is safe and efficacious in maintaining
healing of erosive esophagitis in patients 1 to 11 years of age.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Collaborators:
Calyx CISCRP (Center for Information and Study on Clinical Research Participation) IQVIA RDS Inc. Labcorp Central Laboratory Services Little Journey Ltd. Medidata Solutions Quipment Inc. Thermo Fisher Scientific